TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan
· Delayed Price · Currency is TWD 51.00
-1.10 (-2.11%)
Mar 9, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 2.00 billion as of March 9, 2026. Its market cap has decreased by -13.60% in one year.
Market Cap
2.00B
Enterprise Value
1.80B
Revenue
1.34B
Ranking
n/a
PE Ratio
14.39
Stock Price
51.00
Market Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 2.00B, an increase of 1.95%. That is a compound annual growth rate of 0.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Golden Biotechnology | 2.26B |
| GeneFerm Biotechnology | 1.72B |
| Tien Liang BioTech | 1.65B |
| InnoPharmax | 1.64B |
| Allied Biotech | 2.49B |
| Johnson Chemical Pharmaceutical Works | 2.54B |
| Winston Medical Supply | 1.48B |
| PhytoHealth | 2.71B |